Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2169/internalmedicine.5244-20 http://scihub22266oqcxt.onion/10.2169/internalmedicine.5244-20 32963155!7725631!32963155     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Intern+Med 2020 ; 59 (22): 2945-2949 Nephropedia Template TP {{tp|p=32963155|t=2020. Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19 |pdf=|usr=}}{{32963155}} gab.com Text Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19 JO: Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=32963155 #FOAvip Treatment with tocilizumab (TCZ) to block interleukin-6 (IL-6) signalling is predicted to mitigate cytokine release syndrome (CRS) caused by coronavirus disease 2019 (COVID-19). However, the adverse effects of TCZ on patients with COVID-19 remain unclear. We herein report a patient with COVID-19 treated with TCZ who developed acute hypertriglyceridaemia. Despite favipiravir treatment, acute respiratory distress syndrome developed in a 45-year-old patient with COVID-19; thus, TCZ was initiated. The triglyceride levels greatly increased after TCZ administration. Physicians should consider the negative impact of TCZ on the lipid profile in patients with COVID-19, although COVID-19-induced CRS itself may be an aggravating factor. Twit Text FOAVip Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19 ????Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=32963155 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32963155 #FOAvip English Wikipedia <ref>{{Cite pmid|32963155}}</ref> Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19 #MMPMID32963155 Nakamura H; Miyagi K; Otsuki M; Higure Y; Nishiyama N; Kinjo T; Nakamatsu M; Haranaga S; Tateyama M; Fujita J Intern Med 2020[Nov]; 59 (22): 2945-2949 PMID32963155show ga Treatment with tocilizumab (TCZ) to block interleukin-6 (IL-6) signalling is predicted to mitigate cytokine release syndrome (CRS) caused by coronavirus disease 2019 (COVID-19). However, the adverse effects of TCZ on patients with COVID-19 remain unclear. We herein report a patient with COVID-19 treated with TCZ who developed acute hypertriglyceridaemia. Despite favipiravir treatment, acute respiratory distress syndrome developed in a 45-year-old patient with COVID-19; thus, TCZ was initiated. The triglyceride levels greatly increased after TCZ administration. Physicians should consider the negative impact of TCZ on the lipid profile in patients with COVID-19, although COVID-19-induced CRS itself may be an aggravating factor. |*Betacoronavirus[MESH] |Acute Disease[MESH] |Antibodies, Monoclonal, Humanized/*adverse effects/therapeutic use[MESH] |COVID-19[MESH] |Coronavirus Infections/blood/*drug therapy/epidemiology[MESH] |Humans[MESH] |Hypertriglyceridemia/blood/*chemically induced[MESH] |Interleukin-6/blood[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Pneumonia, Viral/blood/*drug therapy/epidemiology[MESH] |Retrospective Studies[MESH] |SARS-CoV-2[MESH]Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Se(epmc).pdf DeepDyve Pubget Overpricing